Allianz Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Allianz Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-297,400	Closed	-$7.17M	–	2320
2023 Q1	$7.17M	Buy	+297,400	New	+$3.73M	0.01%	823
2020 Q2	–	Sell	-46,439	Closed	-$427K	–	2590
2020 Q1	$427K	Buy	+46,439	New	+$599K	﹤0.01%	2107

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Allianz Asset Management's PRVB Position: Q2 2023 in Review

Allianz Asset Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 297,400 shares — an estimated $7.17M sold.

Allianz Asset Management first reported a position in PRVB in Q1 2020 and held it in 2 quarters. The position peaked at $7.17M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Allianz Asset Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Allianz Asset Management sold 297,400 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.17M.
Allianz Asset Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
Allianz Asset Management's Provention Bio, Inc. Common Stock position peaked at $7.17M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Allianz Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.